One continuing challenge is the need to suppress transplant patients' immune systems to prevent their bodies from rejecting ...

How alterations in cell metabolism translate into specific developmental gene programs remains a major question. This study ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ-PKAc fusion oncoprotein. However, the underlying mechanism of DNAJ-PKAc’s ...